Guideline – Prof. Marcus Maurer

EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis

422.

Agache, I.⁺, Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger T., Eyerich, K. Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P. Y., O’Mahony, L., Schwarze, J., Warner, A., Werfel, T., Palomares, O., and Jutel, M.: EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy 2021: 76; 988-1009. IF: 14.71

o.422

Treatment strategies in urticaria

39.	Kröpfl, L., Maurer, M., and Zuberbier, T.: Treatment strategies in urticaria. Expert Opin. Pharmacother. 2010: 11; 1445-1450. IF: 2.40

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

309

Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. Allergy 2018: 73; 1575-1596. IF: 6.77

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

308

Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. World Allergy Organ. J. 2018: 11; 5. IF: 3.68

o.308